Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

345 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A 3-month evaluation of the efficacy of nedocromil sodium in asthma: a randomized, double-blind, placebo-controlled trial of nedocromil sodium conducted by a Canadian multicenter study group.
Rebuck AS, Kesten S, Boulet LP, Cartier A, Cockcroft D, Gruber J, Laberge F, Lee-Chuy E, Keshmiri M, MacDonald GF, et al. Rebuck AS, et al. Among authors: cockcroft d. J Allergy Clin Immunol. 1990 Mar;85(3):612-7. doi: 10.1016/0091-6749(90)90101-9. J Allergy Clin Immunol. 1990. PMID: 2155958 Clinical Trial.
Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model.
Kidney JC, Boulet LP, Hargreave FE, Deschesnes F, Swystun VA, O'Byrne PM, Choudry N, Morris MM, Jennings B, Andersson N, Andreasson A, Cockcroft DW. Kidney JC, et al. Among authors: cockcroft dw. J Allergy Clin Immunol. 1997 Jul;100(1):65-70. doi: 10.1016/s0091-6749(97)70196-9. J Allergy Clin Immunol. 1997. PMID: 9257789 Clinical Trial.
Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma.
O'Byrne PM, van der Linde J, Cockcroft DW, Gauvreau GM, Brannan JD, Fitzgerald M, Watson RM, Milot J, Davis B, O'Connor M, Hart L, Korducki L, Hamilton AL, Boulet LP. O'Byrne PM, et al. Among authors: cockcroft dw. J Allergy Clin Immunol. 2009 Dec;124(6):1217-21. doi: 10.1016/j.jaci.2009.08.047. J Allergy Clin Immunol. 2009. PMID: 20004781 Clinical Trial.
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses.
Gauvreau GM, Arm JP, Boulet LP, Leigh R, Cockcroft DW, Davis BE, Mayers I, FitzGerald JM, Dahlen B, Killian KJ, Laviolette M, Carlsten C, Lazarinis N, Watson RM, Milot J, Swystun V, Bowen M, Hui L, Lantz AS, Meiser K, Maahs S, Lowe PJ, Skerjanec A, Drollmann A, O'Byrne PM. Gauvreau GM, et al. J Allergy Clin Immunol. 2016 Oct;138(4):1051-1059. doi: 10.1016/j.jaci.2016.02.027. Epub 2016 Apr 7. J Allergy Clin Immunol. 2016. PMID: 27185571 Clinical Trial.
The use of beta-agonists and the risk of death and near death from asthma.
Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, McNutt M, Buist AS, Rebuck AS. Spitzer WO, et al. Among authors: cockcroft d. N Engl J Med. 1992 Feb 20;326(8):501-6. doi: 10.1056/NEJM199202203260801. N Engl J Med. 1992. PMID: 1346340 Free article.
Canadian Thoracic Society guidelines for occupational asthma.
Tarlo SM, Boulet LP, Cartier A, Cockcroft D, Côtè J, Hargreave FE, Holness L, Liss G, Malo JL, Chan-Yeung M. Tarlo SM, et al. Among authors: cockcroft d. Can Respir J. 1998 Jul-Aug;5(4):289-300. doi: 10.1155/1998/587580. Can Respir J. 1998. PMID: 9753529 Free article.
345 results